|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01652 FUSEN PHARM
Nominal 
0.380 +0.020 (+5.556%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 111,286 | -43.315% | 196,322 | 336,437 | 165,611 | 214,212 |
| Cost of Sales | (68,296) | -24.493% | (90,450) | (157,319) | (85,878) | (95,980) |
| Gross Profit | 42,990 | -59.394% | 105,872 | 179,118 | 79,733 | 118,232 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 5,285 | -- | (1,430) | (13,664) | (4,560) | 9,811 | |
| Profit / (Loss) before Taxation | (22,725) | -49.862% | (45,325) | 22,896 | (7,313) | 50,797 | |
| Taxation | (411) | -- | 8,376 | (6,449) | 236 | (6,988) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 8 | 9 | 40 | 110 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (23,136) | -37.370% | (36,941) | 16,456 | (7,037) | 43,919 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 7,816 | 6.253% | 7,356 | 2,241 | 9,931 | 5,862 |
| Depreciation & Amortisation | -- | -- | -- | -- | -- | -- |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | -3.000 | -40.000% | -5.000 | 2.000 | -1.000 | 6.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.570 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | 9.500% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.469 | -- | 0.694 | 0.820 | 0.851 | 0.906 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -23,136 |
| %Change | -37.370% |
| EPS / (LPS) | RMB -0.030 |
| NBV Per Share (¥) | RMB 0.469 |